Viroclinics Biosciences
AcquiredTransforming Clinical Research | Cerba Research
- Headquarters
- Rotterdam
- Business Model
- B2B
- Website
- viroclinics.com
- Last Round
- Growth EquityJan 2019
- Rounds
- 2
- Acquisition Date
- Jan 2022
About
Viroclinics Biosciences is a Dutch contract research organization providing specialized clinical and non-clinical virology services for therapeutics and vaccine development.
Summary
Viroclinics Biosciences is a Biotech company based in Rotterdam, Netherlands. Its most recent funding was a Growth Equity round in Jan 2019. Investors include Summit Partners and Gilde Healthcare.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2022
Sign up to see all 3 rounds
Private Equity through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/viroclinics-biosciences"><img src="https://indexed.vc/api/badge/company/viroclinics-biosciences" alt="Viroclinics Biosciences on Indexed.vc" width="260" height="76" /></a>